These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36963752)

  • 1. Evolution of Pulmonary Involvement in Idiopathic Multicentric Castleman Disease-Not Otherwise Specified: From Nodules to Cysts or Consolidation.
    Zhou J; Zhang L; Liu X; Zhang M; Li J; Zhang W
    Chest; 2023 Aug; 164(2):418-428. PubMed ID: 36963752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can We Differentiate Between Primary Sjögren Syndrome and Idiopathic Multicentric Castleman Disease Based on the Characteristics of Pulmonary Cysts?
    Zhou J; Zhang L; Liu X; Zhang M; Liu Z; Jin Y; Feng R; Shi J; Li J; Zhang W
    J Thorac Imaging; 2024 Sep; 39(5):328-334. PubMed ID: 38624132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival.
    Gao YH; Liu YT; Zhang MY; Li SY; Fajgenbaum DC; Zhang L; Li J
    Br J Haematol; 2024 May; 204(5):1830-1837. PubMed ID: 38356434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
    Yu L; Shi M; Cai Q; Strati P; Hagemeister F; Zhai Q; Li L; Fang X; Li J; Sun R; Zhang S; Yang H; Wang Z; Qian W; Iwaki N; Sato Y; Zhang L; Li J; Oksenhendler E; Xu-Monette ZY; Young KH
    Oncologist; 2020 Nov; 25(11):963-973. PubMed ID: 32852137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review.
    Belyaeva E; Rubenstein A; Pierson SK; Dalldorf D; Frank D; Lim MS; Fajgenbaum DC
    Hematol Oncol; 2022 Apr; 40(2):191-201. PubMed ID: 35104370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.
    Bustamante MS; Pierson SK; Ren Y; Bagg A; Brandstadter JD; Srkalovic G; Mango N; Alapat D; Lechowicz MJ; Li H; Van Rhee F; Lim MS; Fajgenbaum DC
    Haematologica; 2024 Jul; 109(7):2196-2206. PubMed ID: 38205523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of idiopathic multicentric Castleman disease with pulmonary hyalinizing granuloma-like multiple pulmonary nodules.
    Hatano H; Tsujimoto Y; Watanabe H; Tsukada A; Izumi S; Nagasaka S; Igari T; Suzuki M; Iikura M; Hojo M
    Respir Investig; 2023 Jul; 61(4):405-408. PubMed ID: 37099891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peculiar hyper vascular manifestations in idiopathic multicentric castleman disease without tafro syndrome: a case report.
    Jilani RK; Saleem MR; Akhtar S; Jawad W
    Ann Hematol; 2024 Oct; ():. PubMed ID: 39400742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease.
    Nishikori A; Nishimura MF; Nishimura Y; Otsuka F; Maehama K; Ohsawa K; Momose S; Nakamura N; Sato Y
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between transbronchial lung cryobiopsy and surgical lung biopsy in patients with idiopathic multicentric Castleman disease: A report of four cases.
    Otoshi R; Kitamura H; Baba T; Muraoka T; Sekine A; Takemura T; Okudela K; Sawazumi T; Ogura T
    Respir Investig; 2024 Jan; 62(1):1-8. PubMed ID: 37925882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
    González García A; Fernández-Martín J; Robles Marhuenda Á
    Rheumatology (Oxford); 2023 Apr; 62(4):1426-1435. PubMed ID: 35997567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathoracic multicentric Castleman disease: CT findings in 12 patients.
    Johkoh T; Müller NL; Ichikado K; Nishimoto N; Yoshizaki K; Honda O; Tomiyama N; Naitoh H; Nakamura H; Yamamoto S
    Radiology; 1998 Nov; 209(2):477-81. PubMed ID: 9807577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of acute progressive diffuse interstitial lung disease preceding idiopathic multicentric Castleman disease.
    Nabeya D; Yoshimatsu Y; Fujiwara H
    Respir Med Case Rep; 2020; 31():101216. PubMed ID: 32995258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly syndrome: a retrospective study from a large Western cohort.
    Maisonobe L; Bertinchamp R; Damian L; Gérard L; Berisha M; Guillet S; Fieschi C; Malphettes M; Fadlallah J; Hié M; Dunogué B; De Wilde V; Vandergheynst F; Zafrani L; Grall M; Saada N; Garzaro M; Oksenhendler E; Galicier L; Boutboul D
    Br J Haematol; 2022 Feb; 196(3):599-605. PubMed ID: 34585382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
    Lang E; Sande B; Brodkin S; van Rhee F
    Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castleman disease and TAFRO syndrome: To improve the diagnostic consciousness is the key.
    Zhou QY
    World J Clin Cases; 2022 Feb; 10(5):1536-1547. PubMed ID: 35211591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of Castleman disease.
    Dispenzieri A; Fajgenbaum DC
    Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.
    Rubenstein AI; Pierson SK; Shyamsundar S; Bustamante MS; Gonzalez MV; Milller ID; Brandstadter JD; Mumau MD; Fajgenbaum DC
    Br J Haematol; 2024 Mar; 204(3):921-930. PubMed ID: 38168727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report.
    Han PY; Chi HH; Su YT
    World J Clin Cases; 2020 Oct; 8(20):4922-4929. PubMed ID: 33195662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.